Why is Oncology Leading the Way in American Biosimilar Adoption Rates
In the United States, the fight against cancer has become the primary testing ground for the success of biological alternatives. Because these treatments are often among the most expensive in a hospital's inventory, there is a massive incentive to find more affordable options that provide the same clinical results. This high-stakes environment has proven that these "follow-on" products are just...
0 Σχόλια 0 Μοιράστηκε 606 Views 0 Προεπισκόπηση